VTAK VS CPHI Stock Comparison

PerformanceAnalyst Price TargetsEarningsVolatilityTechnicalsProfit
PerformanceAnalyst Price TargetsEarningsVolatilityTechnicalsProfit

Performance

VTAK
10/100

VTAK returned -27.27% in the last 12 months. Based on SPY's performance of 15.17%, its performance is below average giving it a score of 10 of 100.

CPHI
10/100

CPHI returned -92.46% in the last 12 months. Based on SPY's performance of -13.88%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

VTAK
75/100

4 analysts offer 12-month price targets for VTAK. Together, they have an average target of 0, the most optimistic target put VTAK at 0 within 12-months and the most pessimistic has VTAK at 0.

CPHI

"Analyst Price Targets" not found for CPHI

Earnings

VTAK
100/100

VTAK has missed earnings 0 times in the last 20 quarters.

CPHI

"Earnings" not found for CPHI

Volatility

VTAK
48/100

VTAK has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.

CPHI
43/100

CPHI has had a lower than average amount of volatility over the last 12 months giving it a score of 42 of 100.

Technicals

VTAK

"Technicals" not found for VTAK

CPHI
29/100

CPHI receives a 28 of 100 based on 14 indicators. 3 are bullish, 9 are bearish.

Profit

VTAK

"Profit" not found for VTAK

CPHI
13/100

Out of the last 20 quarters, CPHI has had 1 profitable quarters and has increased their profits year over year on 2 of them.

All score calculations are broken down here to help you make more informed investing decisions

Catheter Precision, Inc. Summary

Healthcare
Medical - Devices
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

China Pharma Holdings, Inc. Summary

Healthcare
Drug Manufacturers - Specialty & Generic
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.